Long-term outcomes in myelodysplastic syndrome patients treated with alemtuzumab

Blood Adv. 2019 Apr 9;3(7):980-983. doi: 10.1182/bloodadvances.2018030411.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Intramural